Sharp Shalini
- SEC CIK
- 0001377202
No open-market purchases or sales filed in the past year.
Current role at each company
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sharp Shalini as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NBIX Neurocrine Biosciences Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 (view filing) | May 17 | 4 days | Sharp ShaliniDirector | SSale | −1.11K | $141.90 | −$156.9K | −52.7%994 after | 10b5-1 |